Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
106.15
-0.23 (-0.22%)
At close: Apr 24, 2025, 4:00 PM
102.52
-3.63 (-3.42%)
After-hours: Apr 24, 2025, 6:03 PM EDT
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of $132.33 billion as of April 24, 2025. Its market cap has increased by 53.02% in one year.
Market Cap
132.33B
Enterprise Value
149.42B
1-Year Change
53.02%
Ranking
Category
Stock Price
$106.15
Market Cap Chart
Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $132.33B, an increase of 13,498.83%. That is a compound annual growth rate of 20.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2025 | 132.48B | 15.08% |
Dec 31, 2024 | 115.12B | 14.04% |
Dec 29, 2023 | 100.94B | -6.25% |
Dec 30, 2022 | 107.68B | 18.22% |
Dec 31, 2021 | 91.08B | 24.72% |
Dec 31, 2020 | 73.03B | -11.17% |
Dec 31, 2019 | 82.21B | 1.60% |
Dec 31, 2018 | 80.92B | -13.53% |
Dec 29, 2017 | 93.58B | -0.81% |
Dec 30, 2016 | 94.34B | -35.31% |
Dec 31, 2015 | 145.83B | 2.55% |
Dec 31, 2014 | 142.21B | 23.49% |
Dec 31, 2013 | 115.15B | 106.93% |
Dec 31, 2012 | 55.65B | 81.01% |
Dec 30, 2011 | 30.74B | 4.49% |
Dec 31, 2010 | 29.42B | -24.44% |
Dec 31, 2009 | 38.94B | -16.37% |
Dec 31, 2008 | 46.56B | 8.73% |
Dec 31, 2007 | 42.82B | 43.43% |
Dec 29, 2006 | 29.86B | 24.03% |
Dec 30, 2005 | 24.07B | 58.92% |
Dec 31, 2004 | 15.15B | 28.36% |
Dec 31, 2003 | 11.80B | 76.49% |
Dec 31, 2002 | 6.69B | 6.07% |
Dec 31, 2001 | 6.30B | 61.59% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 772.11B |
UnitedHealth Group | 386.34B |
Johnson & Johnson | 372.82B |
AbbVie | 319.11B |
Novo Nordisk | 276.96B |
Abbott Laboratories | 224.40B |
AstraZeneca | 215.41B |
Novartis AG | 208.99B |